Nuntius Therapeutics
PrivateLast Round
Seed
Mar 23, 2021
Est. Valuation
$1.79M
Total Funding Raised
$125,000
Company Overview
Nuntius Therapeutics is a biotechnology company that develops mRNA and gene-editing therapies using a proprietary, machine-learning-driven nanocarrier platform for cell-specific delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuntius Therapeutics Comparables
Compare Nuntius Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Code Biotherapeutics | 80% | |
| Apertura Gene Therapy | 74% | |
| Bristol Myers Squibb | 73% | |
Nuntius Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 23, 2021 |
Nuntius Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Backed VC | Seed |
| FoundersX Ventures | Seed |
| Uncommon Denominator | Seed |
| Asymmetry Ventures | Seed |
| Y Combinator | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors increased 32% MoM.
- Mar 23, 2021
$125K round led by Y Combinator
Nuntius Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nuntius Therapeutics's valuation, stock price, and market status.